ZYBT
HealthcareZhengye Biotechnology Holding Limited
$1.15
+$0.02 (+1.77%)
Jan 5, 2026
Price History (1Y)
Analysis
Zhengye Biotechnology Holding Limited (ZYBT) is a healthcare company operating in the drug manufacturers - specialty & generic industry. With a market capitalization of $54.50 million and revenue of $153.74 million, the company has a relatively small scale compared to larger players in its sector. Zhengye Biotechnology Holding Limited employs 277 individuals. The company's financial health is concerning, with net income of -$19.368 million and an operating margin of -46.3% over the trailing twelve months (TTM). Furthermore, the company's gross margin stands at 37.4%, while its profit margin is -12.6%. On a positive note, Zhengye Biotechnology Holding Limited has a free cash flow of $24.23 million and cash reserves of $47.63 million, offset by debt of $85.76 million. The valuation context for Zhengye Biotechnology Holding Limited is complex, with an EV/EBITDA ratio of -71.33 and a price to book ratio of 1.28. The company's revenue growth rate over the past year has been negative at -34.4%. Notably, the dividend yield is not applicable due to no reported dividends.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Zhengye Biotechnology Holding Limited
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Visit website →Key Statistics
- Market Cap
- $54.50M
- P/E Ratio
- N/A
- 52-Week High
- $14.30
- 52-Week Low
- $1.11
- Avg Volume
- 52.03K
Company Info
- Exchange
- NCM
- Country
- China
- Employees
- 277